Table 2.

Outcome and patient characteristics according to age at start of prophylactic treatment

Age at start of prophylaxis, yEarly: younger than 4Late: 4 to 7 yVery late: 8 y or older
Patients    
 No. 16 34 26 
 Age at last Pettersson score, y 16.4  (14.2-20.4) 19.7  (16.6-24.4) 20.4  (15.7-27.6)  
 Age at first joint bleed, y 1.3  (0.8-2.0) 2.2  (1.2-2.7) 3.1  (1.7-3.7) 
Treatment    
 Age at start of prophylaxis, y 2.4  (1.4-3.1) 5.4  (4.7-6.9) 10.0  (8.8-12.4)  
 Lag time, y 0.4  (0.0-1.6) 3.2  (1.6-4.5) 7.6  (6.4-10.5)  
 No. of joint bleeds until prophylaxis 3.5  (1-11) 17  (9-38) 100  (60-132)  
Outcome    
 Last Pettersson score (maximum 78) 2  (0-6.5) 8  (2-16) 11.5  (3-23) 
 Pts with last Pettersson above 0, % 50 79 77  
 Clinical score (maximum 90)* 1  (0-2) 3  (1-5) 5  (2-8) 
 Pts with clinical score above 0, % 56 76 81 
Age at start of prophylaxis, yEarly: younger than 4Late: 4 to 7 yVery late: 8 y or older
Patients    
 No. 16 34 26 
 Age at last Pettersson score, y 16.4  (14.2-20.4) 19.7  (16.6-24.4) 20.4  (15.7-27.6)  
 Age at first joint bleed, y 1.3  (0.8-2.0) 2.2  (1.2-2.7) 3.1  (1.7-3.7) 
Treatment    
 Age at start of prophylaxis, y 2.4  (1.4-3.1) 5.4  (4.7-6.9) 10.0  (8.8-12.4)  
 Lag time, y 0.4  (0.0-1.6) 3.2  (1.6-4.5) 7.6  (6.4-10.5)  
 No. of joint bleeds until prophylaxis 3.5  (1-11) 17  (9-38) 100  (60-132)  
Outcome    
 Last Pettersson score (maximum 78) 2  (0-6.5) 8  (2-16) 11.5  (3-23) 
 Pts with last Pettersson above 0, % 50 79 77  
 Clinical score (maximum 90)* 1  (0-2) 3  (1-5) 5  (2-8) 
 Pts with clinical score above 0, % 56 76 81 

Values are numbers or medians (IQR: 25th and 75th percentiles).

*

The clinical score was assessed within 1 year of the last Pettersson score.

Close Modal

or Create an Account

Close Modal
Close Modal